sav have appointed wilson htm for strategic review....and guess what wilson rate sav as a strong buy,the only broker coverage.there you go -- sue them holders
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025